Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Evangelos Giamarellos-Bourboulis and Jesper Eugen-Olsen.
Evangelos Giamarellos-Bourboulis
Connection Strength
0.811
Jesper Eugen-Olsen
  1. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021 10; 27(10):1752-1760.
    View in: PubMed
    Score: 0.241
  2. An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
    View in: PubMed
    Score: 0.233
  3. Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia. Crit Care. 2020 04 30; 24(1):187.
    View in: PubMed
    Score: 0.220
  4. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis. Lancet Rheumatol. 2021 Oct; 3(10):e690-e697.
    View in: PubMed
    Score: 0.060
  5. Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI. J Am Soc Nephrol. 2020 11; 31(11):2725-2735.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.